SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (9332)3/23/1999 9:56:00 AM
From: dlc  Read Replies (1) | Respond to of 17367
 
George, you might want to ask Xoma if the FDA will allow them to release this information. While the ending of the trial is good news, it doesn't tell me anything about the results, and this could take many months. I am under the impression that the mortality data will not be available to the company or the public until the FDA releases it much later in the year. I hope you can verify this with Xoma.



To: aknahow who wrote (9332)3/23/1999 10:35:00 AM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
George, so you think Murphy is that far off? Did you go back to history of trial and excuses Xoma gave the FDA why the trial couldn't last long and may not be able to get that many subjects? What was the ORIGINAL of min. amount of subjects and max. amount? What happened after Brits were brought in? One last question for Opal of April, what are your thoughts on why Xoma could raise 12 million bucks just recently?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News